Results 1 - 20 of 469 for All Library Resources
Sorted by:
Sorted by:
Date-newestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
Refined by:
subject:
Clinical Trials
New From Last 3 Month
New From Last 3 Month
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
An investigation of the impact of atenolol on the risk of all-cause mortality in Asian individuals with hypertension and cardiovascular conditionsBulletin of the National Research Centre, 2024-12, Vol.48 (1), p.51-10 [Peer Reviewed Journal]The Author(s) 2024 ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2522-8307 ;DOI: 10.1186/s42269-024-01208-zFull text available |
| 2 |
Material Type: Article
|
|
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysisDiabetes, obesity & metabolism, 2024-07Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.15572 ;PMID: 38558314Digital Resources/Online E-Resources |
| 3 |
Material Type: Article
|
|
Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 DiabetesThe American journal of cardiology, 2024-06, Vol.221, p.52-63 [Peer Reviewed Journal]2024 Elsevier Inc. ;Copyright © 2024 Elsevier Inc. All rights reserved. ;2024. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2024.04.011 ;PMID: 38641191Digital Resources/Online E-Resources |
| 4 |
Material Type: Web Resources
|
|
Zolmax.com - American Consumer News: Reviewing Windtree Therapeutics (NASDAQ:WINT) and Tarsus Pharmaceuticals (NASDAQ:TARS)Newstex Global Business Blogs, 2024Copyright Newstex Jun 5, 2024Digital Resources/Online E-Resources |
| 5 |
Material Type: Web Resources
|
|
Defense World - American Consumer News: Financial Analysis: Windtree Therapeutics (NASDAQ:WINT) versus Tarsus Pharmaceuticals (NASDAQ:TARS)Defense World [BLOG], 2024Copyright Newstex Jun 5, 2024Digital Resources/Online E-Resources |
| 6 |
Material Type: Web Resources
|
|
Ticker Report - American Consumer News: Financial Analysis: Windtree Therapeutics (NASDAQ:WINT) versus Tarsus Pharmaceuticals (NASDAQ:TARS)Newstex Finance & Accounting Blogs, 2024Copyright Newstex Jun 5, 2024Digital Resources/Online E-Resources |
| 7 |
Material Type: Newsletter Article
|
|
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
| 8 |
Material Type: Newsletter Article
|
|
AstraZeneca: Tagrisso Reduced the Risk of Disease Progression or Death by 84% in Patients With Unresectable, Stage III EGFR-Mutated Lung Cancer vs. Placebo in LAURA Phase III TrialTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
| 9 |
Material Type: Newsletter Article
|
|
Monthly: SeaStar Medical Holding (ICU: 37.14c) falls a second month, trailing 82% of stocksNews Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Jun 3, 2024Digital Resources/Online E-Resources |
| 10 |
Material Type: Newsletter Article
|
|
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trialBusiness Wire, 2024Copyright Business Wire 2024Digital Resources/Online E-Resources |
| 11 |
Material Type: Newsletter Article
|
|
Press Release: TAGRISSO(R) (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trialDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Jun 2, 2024Digital Resources/Online E-Resources |
| 12 |
Material Type: Article
|
|
British Cardiovascular Society Annual Conference, 2024: Vice President Dr Shouvik Haldar’s messageHeart (British Cardiac Society), 2024-06, Vol.110 (11), p.751-752 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-324265 ;PMID: 38729635Full text available |
| 13 |
Material Type: Article
|
|
158 Seasonal variation in remote actigraphy in patients with pulmonary arterial hypertensionHeart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A170-A170 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.155Full text available |
| 14 |
Material Type: Article
|
|
Beta blockers are associated with lower all-cause mortality among HFpEF patientsClinical research in cardiology, 2024-06, Vol.113 (6), p.951-958 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. Springer-Verlag GmbH Germany, part of Springer Nature. ;ISSN: 1861-0684 ;EISSN: 1861-0692 ;DOI: 10.1007/s00392-024-02451-0 ;PMID: 38695899Digital Resources/Online E-Resources |
| 15 |
Material Type: Article
|
|
Causes and Clinical Outcomes of Patients Who Failed Screening for Transcatheter Tricuspid Valve InterventionsThe American journal of cardiology, 2024-06, Vol.220, p.67-76 [Peer Reviewed Journal]2024 Elsevier Inc. ;Copyright © 2024 Elsevier Inc. All rights reserved. ;2024. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2024.03.030 ;PMID: 38582312Digital Resources/Online E-Resources |
| 16 |
Material Type: Newsletter Article
|
|
SeaStar Medical Holding (ICU: 37.0c) lifts 1.0% against the trend; +0.38c [1.0%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd Jun 1, 2024Digital Resources/Online E-Resources |
| 17 |
Material Type: Article
|
|
Propofol vs etomidate for induction prior to invasive mechanical ventilation in patients with acute myocardial infarctionThe American heart journal, 2024-06, Vol.272, p.116-125 [Peer Reviewed Journal]2024 Elsevier Inc. ;Copyright © 2024 Elsevier Inc. All rights reserved. ;2024. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2024.03.013 ;PMID: 38554762Digital Resources/Online E-Resources |
| 18 |
Material Type: Web Resources
|
|
Ticker Report - American Consumer News: Apogee Therapeutics (NASDAQ:APGE) vs. Windtree Therapeutics (NASDAQ:WINT) Financial ContrastNewstex Finance & Accounting Blogs, 2024Copyright Newstex May 31, 2024Digital Resources/Online E-Resources |
| 19 |
Material Type: Web Resources
|
|
Zolmax.com - American Consumer News: Apogee Therapeutics (NASDAQ:APGE) vs. Windtree Therapeutics (NASDAQ:WINT) Financial ContrastNewstex Global Business Blogs, 2024Copyright Newstex May 31, 2024Digital Resources/Online E-Resources |
| 20 |
Material Type: Web Resources
|
|
Zolmax.com - American Consumer News: Critical Survey: Mesoblast (NASDAQ:MESO) and Aptose Biosciences (NASDAQ:APTO)Newstex Global Business Blogs, 2024Copyright Newstex May 30, 2024Digital Resources/Online E-Resources |
Results 1 - 20 of 469 for All Library Resources
Sorted by:
Sorted by:
Date-newestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
New Records
Resource Type
- Newsletter Articles (309)
- Articles (105)
- Web Resources (44)
- Newspaper Articles (7)
- magazinearticle (3)
- Reports (1)
-
More options
Subject
- Heart Failure (460)
- Patients (161)
- Cardiomyopathy (145)
- Ejection Fraction (103)
- Cardiology (100)
- Fda Approval (97)
- Cardiovascular Disease (95)
- Pediatrics (86)
- Mortality (83)
- Biotechnology Industry (81)
- Drug Dosages (76)
- R&d (71)
- Research & Development (71)
- Medical Equipment (70)
- Webcasting (69)
- Science & Technology (64)
- Life Sciences & Biomedicine (61)
- Humans (55)
- Gene Therapy (55)
-
More options
Databases
- ProQuest Central (458)
- PubMed Central (57)
- DOAJ Directory of Open Access Journals (55)
- MEDLINE (54)
- ROAD: Directory of Open Access Scholarly Resources (44)
- Geneva Foundation Free Medical Journals at publisher websites (34)
- SpringerOpen (16)
- HighWire Press (Free Journals) (9)
- ProQuest One Psychology (9)
- Coronavirus Research Database (5)
- BMJ Open Access Journals (4)
- Wiley Online Library Open Access (3)
- Public Library of Science (3)
- Nature Free (2)
- Hyper Article en Ligne (HAL) (Open Access) (2)
- Cambridge Wholly Gold Open Access Journals (1)
- UNSWorks (University of New South Wales) (1)
- Free E- Journals (1)
- SWEPUB Freely available online (1)
- Taylor & Francis Open Access (1)
-
More options
Journal Title
- Biomedicines (3)
- Bmj (3)
- Cardiovascular Diabetology (4)
- Curēus (7)
- Entertainment Close-Up (3)
- Fair Disclosure Wire (4)
- Hcplive (6)
- Industry Snapshots (3)
- Journal Of Clinical Medicine (4)
- Pharmabiz (3)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||